Search
for
Sort by
Research 30 of 1000+
- Ixekizumab improves physical function, quality of life, and work productivity in biologic disease-modifying antirheumatic drug-naive patients with active psoriatic arthritis
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Poly (lactic-co-glycolic acid)-based microneedles for drug delivery across different biological barriers
- Adverse Effects and Drug Interactions of Biologic Agents
- Drug delivery to the hair follicle : role of follicular tight junctions as a biological barrier and the potential for targeting clobetasol nanocarriers
- Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents
- KRDQN: An Interpretable Prediction Framework for Adverse Drug Reactions via Knowledge–Graph Reinforced Deep Q-Learning
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Development of Novel Drug Delivery Systems for the Treatment of Alopecia
- Photo-responsive fibers as artificial hairs in an in-vitro model for transdermal drug delivery
- Editorial: Biomedical advances in ultrasound-mediated drug/molecule delivery
- Biologic: A Double Edged Sword - A Case of Etanercept Induced Alopecia Areata in a Patient with Psoriasis Vulgaris
- Designing, Optimising, and Assessing a Novel Emulgel Containing Minoxidil for Controlled Drug Release, Incorporating Marine-based Polymers
- Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system
- A discourse on human hair fibers and reflections on the conservation of drug molecules
- Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- Recent Advances in Drug Development for Hair Loss
- Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs
- Plant‐derived nanovesicles as potential drug delivery systems for topical use: Emerging applications in dermatology and cosmetology
- A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches
- Surfactants' Role in Nanovesicles Drug Delivery System
- Pharmacological and Biological Efficacy of Chitosan-Based Materials
- Supplementary Material for: Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- Supplementary Material for: Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Treatment options for alopecia: an update, looking to the future
- Inactivated COVID-19 Vaccine Induces a Low Humoral Immune Response in a Subset of Dermatological Patients Receiving Immunosuppressants